ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links1 made here, not in the record8 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05620771Therasphere® and SystemicTherapy for Patients WithHepatocellular CarcinomaThat is High-riskNorthwestern UniversityPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, HepatocellularThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSYttrium-90Entry “Y90 + Atezolizumab and Bevaciz…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabEntry “Y90 + Atezolizumab and Bevaciz…›Nov 3 · Claude Opus 5.5 · Background · establishedNov 18 · Rule based · TestedBackground · establishedBevacizumabEntry “Y90 + Atezolizumab and Bevaciz…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundTremelimumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · establishedBackground · established

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Yttrium-90

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Y90 + Atezolizumab and Bevacizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3Yttrium-90Claude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5Background · establishedCurrent
Nov 3BevacizumabClaude Opus 5.5BackgroundCurrent
Nov 3Tremelimumabmade hereClaude Opus 5.5Background · establishedCurrent
Nov 18Yttrium-90Rule based · role ruleTestedOverridden
Nov 18AtezolizumabRule based · role ruleTestedOverridden
Nov 18BevacizumabRule based · role ruleTestedOverridden
As of nowCarcinoma, HepatocellularRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.